CCO Treatment Updates

Targeting Metastatic Colorectal Cancer: A Focus on Recent Advances

Biology of Tumor Growth and Molecular Targets in Metastatic Colorectal Cancer

Module 1 of 2

Faculty:

Jimmy Hwang, MD
John L. Marshall, MD

CREDIT INFORMATION

Release Date: December 12, 2006

Expiration Date: December 11, 2007

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: The activity is not currently available for credit.

Review the biology of colorectal cancer in this treatment update, which includes discussions of molecular targets in advanced disease and recent clinical trials of targeted agents in combination with chemotherapy.

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss the pathophysiology of colorectal cancer, including the adenoma-carcinoma process and genetic mutations that trigger tumorigenesis
Describe the EGFR and VEGF targets in colorectal cancer and their role in the formation of malignant tumors
Discuss data from studies investigating targeted therapies and combinations of targeted therapies with chemotherapy in the metastatic colorectal cancer setting

Advances in the Management of Metastatic Colorectal Cancer

Module 2 of 2

Faculty:

Syma Iqbal, MD

CREDIT INFORMATION

Release Date: December 08, 2006

Expiration Date: December 07, 2007

Physicians: maximum of 1.5 AMA PRA Category 1 Credits™

Status: The activity is not currently available for credit.

Peruse this treatment update for the most recent data on the management of metastatic colorectal cancer, including a review of continuous vs intermittent chemotherapy, and the integration of targeted agents into standard treatment practices.

Learning Objectives

Upon completion of this activity, participants should be able to:

Recount data on the use of chemotherapeutic agents, including fluoropyrimidines, alkylating agents, and topoisomerase inhibitors, for treatment of metastatic colorectal cancer
Describe investigations of targeted therapies in combination with standard treatments for the management of advanced colorectal cancer
Describe novel treatment strategies currently under investigation, including the use of intermittent chemotherapy and the combination of several active therapies, for the treatment of patients with advanced colorectal cancer

CCO Slidesets

Targeting Metastatic Colorectal Cancer: A Focus on Recent Advances

Format: UNKNOWN | File size: 15.92 MB | Date posted: 12/11/2006

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.